Fabio A.B. Schutz
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 5%
- Surgery top 5%
- Co-authors
- Toni K. ChoueiriYoujin JeJoaquim BellmuntJonathan E. RosenbergPaul L. NguyenGeorges AzziCora N. SternbergGuru Sonpavde
- Topics
- Renal cell carcinoma treatment (13 papers)Bladder and Urothelial Cancer Treatments (8 papers)Cancer Treatment and Pharmacology (8 papers)
- Partner nations
- United StatesBrazilSpain
In The Last Decade
Fabio A.B. Schutz
44 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 1.2k
- Molecular Biology 638
- Cardiology and Cardiovascular Medicine 592
- Surgery 533
Countries citing papers authored by Fabio A.B. Schutz
This map shows the geographic impact of Fabio A.B. Schutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio A.B. Schutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio A.B. Schutz more than expected).
Fields of papers citing papers by Fabio A.B. Schutz
This network shows the impact of papers produced by Fabio A.B. Schutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio A.B. Schutz. The network helps show where Fabio A.B. Schutz may publish in the future.
Co-authorship network of co-authors of Fabio A.B. Schutz
This figure shows the co-authorship network connecting the top 25 collaborators of Fabio A.B. Schutz. A scholar is included among the top collaborators of Fabio A.B. Schutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio A.B. Schutz. Fabio A.B. Schutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 19 | |
| 5 | 8 | |
| 6 | 10 | |
| 7 | 1 | |
| 8 | 11 | |
| 9 | Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patientsbreakdown → | 369 |
| 10 | 10 | |
| 11 | 69 | |
| 12 | 50 | |
| 13 | 64 | |
| 14 | 11 | |
| 15 | 32 | |
| 16 | 3 | |
| 17 | 23 | |
| 18 | 113 | |
| 19 | 147 | |
| 20 | 220 |
About Fabio A.B. Schutz
Fabio A.B. Schutz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology, having authored 46 papers that have together received 2.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (13 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Cancer Treatment and Pharmacology (8 papers). The work is most often cited by research in Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.2k citations) and Internal Medicine (132 citations). Fabio A.B. Schutz has collaborated with scholars based in United States, Brazil and Spain. Frequent co-authors include Toni K. Choueiri, Youjin Je, Joaquim Bellmunt, Jonathan E. Rosenberg, Paul L. Nguyen, Georges Azzi, Cora N. Sternberg, Guru Sonpavde, Guillermo de Velasco and Raphael Brandão Moreira. Their work appears in journals such as JAMA, Journal of Clinical Oncology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.